1. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia 
F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer, Z.F. Forycki, P.M. Shah 
Clinical Microbiology and Infection 
Volume 8, Issue 2, Pages (February 2002)
DOI: /j x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Box-plot of body temperature (°C) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
Box-plot of white blood cell count (WBC) (cells/nL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

4. Figure 3
Box-plot of body APACHE II scores in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

5. Figure 4
Box-plot of C-reactive protein (CRP) serum concentrations (mg/dL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

6. Figure 5
Box-plot of procalcitonin (PCT; ng/mL) in surviving and nonsurviving patients with pneumonia; day 0 = onset of clinical signs of infections.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions